Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 18.49B | 17.62B | 16.51B | 15.47B | 8.79B |
Gross Profit | 2.30B | 2.21B | 1.97B | 1.73B | 1.39B |
EBITDA | 1.26B | 762.00M | 766.00M | 732.00M | 655.00M |
Net Income | 149.00M | -309.00M | -128.00M | -576.00M | 247.00M |
Balance Sheet | |||||
Total Assets | 34.59B | 33.25B | 31.40B | 30.52B | 28.57B |
Cash, Cash Equivalents and Short-Term Investments | 2.27B | 976.00M | 826.00M | 810.00M | 1.25B |
Total Debt | 3.52B | 4.66B | 3.70B | 3.69B | 2.93B |
Total Liabilities | 24.01B | 24.48B | 22.29B | 21.49B | 19.45B |
Stockholders Equity | 10.46B | 8.67B | 9.00B | 8.91B | 9.04B |
Cash Flow | |||||
Free Cash Flow | 490.00M | -567.00M | 175.00M | -1.00B | -720.00M |
Operating Cash Flow | 972.00M | -82.00M | 606.00M | -577.00M | -455.00M |
Investing Cash Flow | 123.00M | -431.00M | -478.00M | -443.00M | -1.94B |
Financing Cash Flow | 244.00M | 696.00M | -61.00M | 558.00M | 1.46B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | €14.67B | 13.85 | 8.49% | 5.19% | 1.24% | 2.36% | |
75 Outperform | $145.02B | 32.66 | 21.75% | 1.57% | 5.16% | 12.89% | |
75 Outperform | €70.16B | 14.75 | 16.75% | 5.88% | 4.08% | 3.07% | |
73 Outperform | €11.36B | 10.59 | 15.80% | 4.01% | 7.37% | 3.85% | |
70 Outperform | €116.48B | 62.44 | -6.13% | 1.04% | 17.19% | -119.44% | |
64 Neutral | €9.25B | 65.65 | 1.54% | 1.24% | 4.94% | ― | |
58 Neutral | HK$14.16B | 4.43 | -3.01% | 7.13% | 3.67% | -54.16% |